A Northwestern Medicine study, the first of its kind, estimated lifetime risk for sudden cardiac death, finding that one in every nine men and one in every 30 women will be affected, most of whom with no previous symptoms.
Northwestern Medicine scientists and collaborators discovered that mutations in the TEK gene lead to primary congenital glaucoma, validating previous findings in mice and suggesting a target for future therapies.
Scientists at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University will test Guardant Health’s technology to detect cancer at early stages in high-risk populations.
Mutations in a gene called TMEM230 were definitively linked to confirmed cases of the common movement disorder in a recent Northwestern Medicine study.
Navdeep Chandel, PhD, David W. Cugell Professor of Medicine, has received the National Cancer Institute’s Outstanding Investigator Award to explore how mitochondrial metabolism plays a role in cancer.
Certain anatomical properties of the brain – not the initial injury – determine most of a patient’s risk of developing chronic pain, according to a new study.
The results of a recent study co-authored by C. David James, PhD, uncovered potential new targets for treating glioblastoma, a fatal brain tumor for which there is currently no cure.
Scientists have created a glowing map of the very first cells to be infected with an HIV-like virus, pinpointing the vulnerable points where HIV may enter the female reproductive tract.